rs1057910(C;C)
CYP2C9*3 homozygote; average 80% reduction in warfarin metabolism; reduced metabolism of number of other drugs
- Magnitude
- 4.0Very important
- Repute
- Bad
- Frequency
- <1%Average of 9 populations
- On SNPedia
- rs1057910(C;C)
- Gene
- CYP2C9
Frequency
Share of people with C;C in each HapMap population.
- Gujarati Indian1%
- European ancestry (Utah)0%
- Han Chinese (Beijing)0%
- Japanese (Tokyo)0%
- Yoruba (Nigeria)0%
- African ancestry (Southwest US)0%
- Chinese (Denver)0%
- Mexican ancestry (Los Angeles)0%
- Tuscan0%
Other genotypes of rs1057910
Notes
From SNPedia
* 12x risk of severe cutaneous adverse reactions when taking antiepileptic drug phenytoin. * rs1057910(C;C) genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates will lead to higher internal concentrations of the drug. It is not clear whether this could lead to increased efficacy and/or increased side effects. * rs1057910(C;C) genotypes are poor metabolizers of tolbutamide, a sulfonylurea hypoglycemic drug used in the treatment of diabetes. * rs1057910(C;C) genotypes are poor metabolizers of phenytoin, a drug used to treat epilepsy, and therefore tend to need lower doses. * rs1057910(C;C) genotypes are poor metabolizers of glipizide, a second generation sulfonylurea drug structurally similar to tolbutamide and also used as an oral hypoglycemic agent. * rs1057910(C;C) genotypes are poor metabolizers of warfarin, and therefore unusually sensitive.
Related
Source and license
Adapted from rs1057910(C;C) on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.